Study of 99 million vaccinated individuals confirms pre-established safety signals for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis
Since declaration of the COVID-19 pandemic by the World Health Organization (WHO) on March 11, 2020 more than 13.5 billion doses of COVID-19 vaccines have been administered worldwide; and as of November 2023, at least 70.5 % of the world’s population had received at least one dose of a COVID-19 vaccine. This study was a multi-country analysis that confirmed pre-established safety signals for myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis. Other potential safety signals that require further investigation were also identified. Largest-ever COVID vaccine study links shot to small increase in heart and brain conditions | Fox News COVID-19 vaccine linked to possible health issues, study finds - NEWS NATION SOURCE STUDY ... COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals - ScienceDirect BACKGROUND ... Clinical Considerations: Myocarditi...